NEU has never pretended that trofinetide is a cure for Retts Syndrome.
That's why the $100k per year cost (to me) seems out of proportion.
Ann: Notification of investor briefing webinar, page-28
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.24 |
Change
0.390(3.04%) |
Mkt cap ! $1.652B | |||
| Open | High | Low | Value | Volume |
| $13.15 | $13.37 | $12.92 | $4.200M | 320.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 456 | $13.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.25 | 234 | 5 |
View Market Depth
| Last trade - 12.07pm 18/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |